AI Innovation Explodes At ZGC Forum--WeMed Medical Showcases Cardiovascular And Cerebrovascular Solutions
On April 29, the highly anticipated 2024 Zhongguancun Forum concluded successfully. WeMed Medical, the leading full-process solution provider for interventional diagnosis and treatment in China, made a stunning debut with the new generation DSA of Taikon Series and Endovascular Robotic System. It applies AI to empower interventional diagnosis and treatment, bringing revolutionary breakthroughs in the treatment of cardiovascular and cerebrovascular diseases.
Cardiovascular and cerebrovascular diseases have high morbidity and mortality rates, as "health killers" in today's society . According to statistics, the number of deaths caused by cardiovascular and cerebrovascular diseases accounts for nearly one-third of global deaths every year, bringing huge pain and burden to patients and their families. However, traditional medical imaging technology often has problems such as unclear imaging and complex operations, making it difficult to meet the needs of precise treatment and real-time guidance of intraoperative images.
WeMed Medical's next-generation Angiography X-ray System -- Taikon Series has been created. This product utilizes cutting-edge imaging technology and AI intelligent algorithms, achieving breakthroughs in intelligent imaging, precision, high definition, and real-time imaging. In the diagnosis and treatment of cardiovascular and cerebrovascular diseases, the new generation Taikon Series Intelligent DSA can clearly present the structure and lesions of blood vessels, providing doctors with more accurate and comprehensive information, thus enabling the formulation of more precise treatment plans.
Compared to traditional DSA technology, the new generation Taikon Series not only offers superior imaging results, but also features simpler operation. Doctors can swiftly obtain and analyze imaging data with the assistance of intelligent algorithms, reducing errors caused by human factors and enhancing the precision and safety of surgeries. This not only helps alleviate patient suffering and recovery time, but also improves the success rate of surgeries and patient survival rates.
During the forum, Mr. Tian Wei, the marketing director of WeMed Medical gave a keynote speech titled "Prospects of the Next Generation 'Space' Intelligent Angiography X-ray Machine," delving into the application prospects of the new generation intelligent DSA in the treatment of cardiovascular and cerebrovascular diseases. He mentioned that with the continuous development of artificial intelligence technology, the intelligent processing of medical imaging will become an important trend in the future of the medical field.
